All News #Library
Biotech
Atalanta Therapeutics Announces Leadership Transitions
18 Jun 2025 //
BUSINESSWIRE
Atalanta Publishes Data on RNAi Therapy for KCNT1-Related Epilepsy
08 Apr 2025 //
BUSINESSWIRE
Atalanta Therapeutics Raises $97M To Advance RNAi Therapies For CNS
28 Jan 2025 //
BUSINESSWIRE
EQT Lead 75 M Series B in Atalanta for Epilepsy, Huntington Disease
28 Jan 2025 //
PR NEWSWIRE

Market Place
Sourcing Support